Recent Research Funding

We receive funding from a variety of sources that recognize the value of our high-impact research.

  • Biomimetic Vascular Matrix for Vascular Smooth Muscle Cell Mechanobiology and Pathology. Vincent Tutino (Co-Investigator). National Institutes of Health – NHLBI. $4,000,000. 9/1/2023-8/1/2027.
  • Biomimetic Vascular Matrix for Vascular Smooth Muscle Cell Mechanobiology and Pathology. Yongho Bae (Principal Investigator). NIH/NHLBI. $2,266,072. 9/1/2023-6/1/2027.
  • Immunomodulatory Therapy After Resuscitation From Cardiac Arrest. Olga Pletnikova (Consultant). NIH. 1/1/2022-12/1/2026.
  • Liquid and endovascular coil biopsy for understanding sex differences in Intracranial Aneurysms. Vincent Tutino (Co-Investigator). CNS – Joint CV Section/CNSF Young Investigator’s Award. $150,000. 10/1/2023-9/1/2026.
  • The Effect of WTC Exposure on Thyroid Cancer in the Survivor Population. Scott Doyle (Co-Investigator). NIH. $100,297. 7/1/2023-6/1/2026.
  • An AI-Enhanced Angiographic System to Guide Endovascular Treatment of Intracranial Aneurysms. Vincent Tutino (Co-Investigator). National Science Foundation. $1,000,000. 5/1/2023-4/1/2025.
  • Collaborative Research: Control of Information Processing and Learning in Neuronal Networks through Light-mediated Programming of Genomic Networks. Yongho Bae (Co-Principal Investigator). National Science Foundation. $366,284. 2/1/2021-1/1/2025.
  • Buffalo Bioimaging Brain Bank for Neurological Disorders (B4ND). Olga Pletnikova (Co-Principal Investigator). Translational Pilot Studies Program University at Buffalo Clinical and Translational Science Institute Clinical and Translational Science Award (CTSA). $68,000. 1/1/2024-12/1/2024.
  • Initiative for Private and Secure Collaborative AI Training in Computational Pathology. Scott Doyle (Principal Investigator). Clinical and Translational Science Institute (CTSI). $50,000. 1/1/2024-12/1/2024.
  • Discovery and Development of novel inhibitors and other potential targets to reduce or prevent arterial stiffening. Yongho Bae (Principal Investigator). Center of Excellence in Bioinformatics and Life Sciences, University at Buffalo. $60,000. 12/1/2023-11/1/2024.
  • Disrupting ion channel scaffolding to treat neuropathic pain. Tracey Ignatowski (Co-Investigator). NIH. $1,901,926. 9/1/2019-8/1/2024.
  • Hemodynamically-Induced Molecules Regulating the Initiation of Intracranial Aneurysm. Vincent Tutino (Co-Principal Investigator). National Institutes of Health – NINDS. $475,000. 7/1/2022-8/1/2024.
  • Development of a Molecular Diagnostic to Identify Dangerous Intracranial Aneurysms. Vincent Tutino (Co-Principal Investigator). National Institutes of Health – NINDS. $2,900,000. 9/1/2023-8/1/2024.
  • Validation of a Blood-Based Diagnostic Assay for Rupture Risk Assessment of Intracranial Aneurysms. Vincent Tutino (Principal Investigator). Center for Advanced Technology (NYSTAR). $117,000. 6/1/2022-6/1/2024.
  • Drug Discovery Incubator Program Award. Yongho Bae (Principal Investigator). Empire Discovery Institute. $250,000. 11/1/2022-5/1/2024.
  • Quantitative Risk Model for Predicting Likelihood of Recurrence for Oral Cavity Cancer. Scott Doyle (Principal Investigator). NIH. $2,003,024. 4/1/2020-3/1/2024.
  • On the Control of Neuronal Networks through Light-mediated Programming of Genomic Networks. Michal Stachowiak (Principal Investigator). National Science Foundation. 3/1/2021-3/1/2024.
  • Cannabis vaping-induced inflammasome activation and chronic lung inflammation. Tracey Ignatowski (Co-Principal Investigator). Center for Cannabis and Cannabinoid Research (CeCaR) Pilot Study Program, University at Buffalo. $10,000. 1/1/2023-3/1/2024.
  • Biomimetic Vascular Matrix for Vascular Smooth Muscle Cell Mechanobiology and Pathology. Yongho Bae (Principal Investigator). NIH/NHLBI. $639,543. 9/1/2022-8/1/2023.
  • Biomarker Discovery and Validation in PSP. Olga Pletnikova (Contributor). NIH. $576,476. 8/1/2018-4/1/2023.